Details

Urejanje gozdnega prostora : osnove načrtovanja in gospodarjenja z gozdovi
ID Bončina, Andrej (Author)

.pdfPDF - Presentation file, Download (50,56 MB)
MD5: 23D0274B7E9CD32E88297EDF77310AA3

Language:Slovenian
Keywords:gozdni prostor, urejanje gozdov, gozdarsko načrtovanje, gospodarjenje z gozdovi, trajnostno gospodarjenje z gozdovi
Work type:Higher education textbook
Typology:2.05 - Other Educational Material
Organization:BF - Biotechnical Faculty
Publication status:Published
Place of publishing:Ljubljana
Publisher:Oddelek za gozdarstvo in obnovljive gozdne vire
Year:2012
Number of pages:99 str.
PID:20.500.12556/RUL-126097 This link opens in a new window
UDC:630*61
COBISS.SI-ID:3412902 This link opens in a new window
Publication date in RUL:12.04.2021
Views:5649
Downloads:208
Metadata:XML DC-XML DC-RDF
:
BONČINA, Andrej, 2012, Urejanje gozdnega prostora : osnove načrtovanja in gospodarjenja z gozdovi [online]. Other Educational Material. Ljubljana : Oddelek za gozdarstvo in obnovljive gozdne vire. [Accessed 25 March 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=126097
Copy citation
Share:Bookmark and Share

Similar documents

Similar works from RUL:
  1. ǂThe ǂimportance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Study of phosphatidylethanolamine N-methyltransferase gene expression in non-small cell lung cancer tissue
  4. Usefulness of immunohistochemically determined epidermal growth factor receptor mutations in lung cancer
  5. Diabetes mellitus and physical activity
Similar works from other Slovenian collections:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Back